EUVIMEDEUVIMED entdecken
Crossref

Outcomes With the WATCHMAN FLX in Everyday Clinical Practice From the NCDR Left Atrial Appendage Occlusion Registry

Samir R Kapadia, Robert W Yeh iD, Matthew J Price iD, Jonathan P Piccini iD, Devi G Nair iD, Agam Bansal, Jonathan C Hsu iD, James V Freeman iD, Thomas Christen, Dominic J Allocco iD, Douglas N Gibson iD

Circulation: Cardiovascular Interventions · 2024-09 · 17 (9)

DOI: 10.1161/circinterventions.123.013750 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Cardiovascular Interventions, 2024-09. Verfasst von Samir R Kapadia und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, OH (S.R.K., A.B.). Hauptthemen laut MEDLINE: Atrial Appendage, Registries, Atrial Fibrillation. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: PINNACLE FLX (Protection Against Embolism for Nonvalvular AF Patients: Investigational Device Evaluation of the WATCHMAN FLX LAA Closure Technology) demonstrated improved outcomes and low incidence of adverse events with the WATCHMAN FLX device in a controlled setting. The National Cardiovascular Disease Registry’s Left Atrial Appendage Occlusion Registry was utilized to assess the safety and effectiveness of WATCHMAN FLX in contemporary clinical practice in the United States. METHODS: The WATCHMAN FLX Device Surveillance Post Approval Analysis Plan used data from the Left Atrial Appendage Occlusion registry to identify patients undergoing WATCHMAN FLX implantation between August 2020 and September 2022. The key safety end point was defined as all-cause death, ischemic stroke, systemic embolism, or device or procedure-related events requiring open cardiac surgery or major endovascular intervention between device implantation and hospital discharge. Major adverse events were reported at hospital discharge, 45 days, and 1 year. RESULTS: Among 97 185 patients in the Left Atrial Appendage Occlusion registry undergoing WATCHMAN FLX, successful implantation occurred in 97.5% (n=94 784) of patients. The key safety end point occurred in 0.45% of patients. At 45 days post-procedure, all-cause death occurred in 0.81% patients, ischemic stroke in 0.23%, major bleeding in 3.1%, pericardial effusion requiring intervention in 0.50%, device-related thrombus in 0.44%, and device embolism in 0.04% patients. No peri-device leak was observed in 83.1% of patients at 45 days. At 1 year, the rate of all-cause death was 8.2%, the rate of any stroke was 1.5% (ischemic stroke, 1.2%), and major bleeding occurred in 6.4% of patients. CONCLUSIONS: In a large contemporary cohort of patients with the WATCHMAN FLX device, the rates of implant success and clinical outcomes through 1 year were comparable with the PINNACLE FLX study, demonstrating that favorable outcomes achieved in the pivotal approval study can be replicated in routine clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial AppendageRegistriesAtrial FibrillationHumansFemaleMaleAgedTreatment OutcomeUnited StatesTime FactorsRisk FactorsAged, 80 and overCardiac CatheterizationRisk AssessmentProduct Surveillance, PostmarketingEmbolic Protection DevicesIschemic StrokeProsthesis DesignMiddle Aged

Stichwörter der Autor:innen

atrial appendageatrial fibrillationhospitalpericardial effusionregistries

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, OH (S.R.K., A.B.).
  • Department of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA (R.W.Y.).
  • Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, CA (M.J.P., D.N.G.).
  • Division of Cardiology, Duke University Medical Center, Durham, NC (J.P.P.).
  • St Bernard's Heart and Vascular Center, Jonesboro, AR (D.G.N.).
  • Cardiac Electrophysiology Section, Division of Cardiology, Department of Medicine, University of California, San Diego (J.C.H.).

ORCID-Profile: Robert W Yeh, Matthew J Price, Jonathan P Piccini, Devi G Nair, Jonathan C Hsu, James V Freeman, Dominic J Allocco, Douglas N Gibson

Zitieren

APA

Kapadia, S. R., Yeh, R. W., Price, M. J., Piccini, J. P., Nair, D. G., Bansal, A., Hsu, J. C., Freeman, J. V., Christen, T., Allocco, D. J., & Gibson, D. N. (2024). Outcomes With the WATCHMAN FLX in Everyday Clinical Practice From the NCDR Left Atrial Appendage Occlusion Registry. Circulation: Cardiovascular Interventions, 17(9). https://doi.org/10.1161/circinterventions.123.013750

Vancouver

Kapadia SR, Yeh RW, Price MJ, Piccini JP, Nair DG, Bansal A, et al. Outcomes With the WATCHMAN FLX in Everyday Clinical Practice From the NCDR Left Atrial Appendage Occlusion Registry. Circulation: Cardiovascular Interventions. 2024;17(9). doi:10.1161/circinterventions.123.013750

BibTeX
@article{Kapadia2024,
  author = {Kapadia, Samir R and Yeh, Robert W and Price, Matthew J and Piccini, Jonathan P and Nair, Devi G and Bansal, Agam and Hsu, Jonathan C and Freeman, James V and Christen, Thomas and Allocco, Dominic J and Gibson, Douglas N},
  title = {Outcomes With the WATCHMAN FLX in Everyday Clinical Practice From the NCDR Left Atrial Appendage Occlusion Registry},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2024},
  volume = {17},
  number = {9},
  doi = {10.1161/circinterventions.123.013750}
}
Kostenlos starten →